Evidence map›Paper›PMID 19401776›Full record

ArticlePloS one2009

Site directed mutagenesis of amino acid residues at the active site of mouse aldehyde oxidase AOX1.

Silvia Schumann, Mineko Terao, Enrico Garattini, Miguel Saggu, Friedhelm Lendzian, Peter Hildebrandt, Silke Leimkühler

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 40 citations in OpenAlex.

  1. Functional mononuclear molybdenum enzymes: challenges and triumphs in molecular cloning, expression, and isolation.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2020
    Review
  2. Review
  3. Molybdenum-Containing Enzymes.Methods in molecular biology (Clifton, N.J.) · 2019
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The mononuclear molybdenum enzymes.Chemical reviews · 2014
    Review
  9. Evaluation of rhesus monkey and guinea pig hepatic cytosol fractions as models for human aldehyde oxidase.Drug metabolism and disposition: the biological fate of chemicals · 2013
    Article
  10. Article
  11. Article
  12. Article
  13. The impact of single nucleotide polymorphisms on human aldehyde oxidase.Drug metabolism and disposition: the biological fate of chemicals · 2012
    Article
  14. Article
  15. Article
  16. Purification and mechanism of human aldehyde oxidase expressed in Escherichia coli.Drug metabolism and disposition: the biological fate of chemicals · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Silvia SchumannUniversität Potsdam, Institut für Biochemie and Biologie, Potsdam, Germany.
Mineko Terao
Enrico Garattini
Miguel Saggu
Friedhelm Lendzian
Peter Hildebrandt
Silke Leimkühler
Technische Universität Berlin · DEMario Negri Institute for Pharmacological Research · ITUniversity of Potsdam · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mouse aldehyde oxidase (mAOX1) forms a homodimer and belongs to the xanthine oxidase family of molybdoenzymes which are characterized by an essential equatorial sulfur ligand coordinated to the molybdenum atom. In general, mammalian AOs are characterized by broad substrate specificity and an yet obscure physiological function. To define the physiological substrates and the enzymatic characteristics of mAOX1, we established a system for the heterologous expression of the enzyme in Escherichia coli. The recombinant protein showed spectral features and a range of substrate specificity similar to the native protein purified from mouse liver. The EPR data of recombinant mAOX1 were similar to those of AO from rabbit liver, but differed from the homologous xanthine oxidoreductase enzymes. Site-directed mutagenesis of amino acids Val806, Met884 and Glu1265 at the active site resulted in a drastic decrease in the oxidation of aldehydes with no increase in the oxidation of purine substrates. The double mutant V806E/M884R and the single mutant E1265Q were catalytically inactive enzymes regardless of the aldehyde or purine substrates tested. Our results show that only Glu1265 is essential for the catalytic activity by initiating the base-catalyzed mechanism of substrate oxidation. In addition, it is concluded that the substrate specificity of molybdo-flavoenzymes is more complex and not only defined by the three characterized amino acids in the active site.

Indexed as

Aldehyde OxidaseAmino Acid SubstitutionAnimalsCatalytic DomainCircular DichroismElectron Spin Resonance SpectroscopyEscherichia coliGlutamic AcidIn Vitro TechniquesKineticsMiceModels, ChemicalMutagenesis, Site-DirectedOxidation-ReductionRecombinant ProteinsRhodobacter capsulatusAldehyde OxidaseGlutamic AcidRecombinant ProteinsXanthine Dehydrogenase

Identifiers

PMID19401776
PMCPMC2671166
OpenAlexW2029763857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.